[Controversial judgment in the Dortmund federal court. Is patient education superfluous when everything is written down in the package insert?].
Rigizahn
E F
EF
D004338:Drug Combinations; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D004958:Estradiol / Q000009:adverse effects; D005260:Female; D005858:Germany; D006801:Humans; D006908:Hydroxyprogesterones / Q000009:adverse effects; D007258:Informed Consent / Q000331:legislation & jurisprudence*; D010353:Patient Education as Topic / Q000331:legislation & jurisprudence*; D012307:Risk Factors; D013924:Thrombophlebitis / Q000139:chemically induced
D004338:Drug Combinations; D006908:Hydroxyprogesterones; C003210:primosiston; D004958:Estradiol